Susquehanna International Group, LLP Zentalis Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 121,095 shares of ZNTL stock, worth $379,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,095

Previous 44,077 174.74%

Holding current value

$379,027

Previous $180,000 146.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $223,352 - $351,972	77,018 Added 174.74%	121,095 $444,000
Q2 2024 Aug 15, 2024	BUY	$4.09 - $16.13 $69,734 - $275,016	17,050 Added 63.09%	44,077 $180,000
Q1 2024 May 07, 2024	SELL	$10.83 - $16.49 $92,758 - $141,236	-8,565 Reduced 24.06%	27,027 $425,000
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $110,739 - $226,543	11,254 Added 46.24%	35,592 $539,000
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $188,133 - $271,131	9,584 Added 64.96%	24,338 $488,000
Q2 2023 Aug 11, 2023	SELL	$17.41 - $30.05 $1.12 Million - $1.94 Million	-64,533 Reduced 81.39%	14,754 $416,000
Q1 2023 May 16, 2023	BUY	$16.14 - $24.94 $921,271 - $1.42 Million	57,080 Added 257.04%	79,287 $1.36 Million
Q4 2022 Feb 14, 2023	SELL	$18.07 - $25.6 $954,348 - $1.35 Million	-52,814 Reduced 70.4%	22,207 $447,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $1.34 Million - $2.1 Million	66,153 Added 745.97%	75,021 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $381,447 - $1.11 Million	-21,298 Reduced 70.6%	8,868 $249,000
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $71,808 - $139,697	-1,727 Reduced 5.41%	30,166 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $1.1 Million - $1.4 Million	-16,458 Reduced 34.04%	31,893 $2.68 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $1.45 Million - $2.28 Million	30,978 Added 178.31%	48,351 $3.22 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $406,384 - $676,221	10,863 Added 166.87%	17,373 $924,000
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $4,211 - $6,220	118 Added 1.85%	6,510 $282,000
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $202,690 - $370,544	6,392 New	6,392 $332,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $178M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Zentalis Pharmaceuticals, Inc. Transaction History